Literature DB >> 32750558

The 8th TNM classification for oral squamous cell carcinoma: What is gained, what is lost, and what is missing.

Davide Mattavelli1, Marco Ferrari2, Stefano Taboni3, Riccardo Morello3, Alberto Paderno3, Vittorio Rampinelli3, Francesca Del Bon3, Davide Lombardi3, Alberto Grammatica3, Paolo Bossi4, Alberto Deganello3, Cesare Piazza5, Piero Nicolai6.   

Abstract

OBJECTIVES: The 8th TNM edition remarkably changed the classification of T and N categories for oral squamous cell carcinoma (OSCC). The present study aims at evaluating the improvement in prognostic power compared to the 7th edition, pros and cons of the modifications, and parameters deserving consideration for further implementations.
MATERIALS AND METHODS: All OSCCs treated with upfront surgery at our institution between 2002 and 2017 were included. Demographics, clinical-pathological and treatment variables were retrieved. All tumors were classified according to both the 7th and 8th TNM edition, and patients were grouped according to the shift in T category and stage. Survivals were calculated with the Kaplan-Meier method. Univariate and multivariate analysis were carried out. Receiver Operating Characteristics (ROC) curve analyses were performed to find the best cut-off of DOI (in patients with DOI > 10 mm) and number of involved nodes (in positive neck patients).
RESULTS: 244 patients were included. T, N categories, and stage changed in 59.2%, 20.5%, and 49.1% patients, respectively; 41.5% of patients were upstaged. The new T classification well depicted prognosis according to OS. Five-year overall (OS), disease-specific, recurrence-free (RFS) survivals were 60.5%, 70.9%, 59.8%, respectively. According to ROC curves, DOI > 20 mm and 4 positive nodes were the best cutoffs for OS and RFS.
CONCLUSION: The novelties introduced in 8th TNM edition were positive. DOI > 20 mm for T4 definition and number of positive nodes (0, <4, 4 or more) for N classification emerged as the most urgent factors to be implemented.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  8th TNM edition; Depth of invasion; Nodal metastasis; Number of positive nodes; Oral cancer; Oral squamous cell carcinoma; Perineural invasion

Year:  2020        PMID: 32750558     DOI: 10.1016/j.oraloncology.2020.104937

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  5 in total

1.  Oral tongue carcinoma: prognostic changes according to the updated 2020 version of the AJCC/UICC TNM staging system.

Authors:  Marta Tagliabue; Rita De Berardinis; Pietro Belloni; Sara Gandini; Donatella Scaglione; Fausto Maffini; Rosolino Antonino Mirabella; Stefano Riccio; Giugliano Gioacchino; Roberto Bruschini; Francesco Chu; Mohssen Ansarin
Journal:  Acta Otorhinolaryngol Ital       Date:  2022-04       Impact factor: 2.618

Review 2.  Head and neck cancer patients declining curative treatment: a case series and literature review.

Authors:  Axel Sahovaler; Tommaso Gualtieri; David Palma; Kevin Fung; S Danielle MacNeil; John Yoo; Anthony Nichols
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-02       Impact factor: 2.124

3.  Editorial: Oral Oncology: From Precise Surgery to Precision Medicine and Surgery.

Authors:  Zuzana Saidak; Cesare Piazza
Journal:  Front Oral Health       Date:  2022-04-28

4.  Risk Stratification in Oral Cancer: A Novel Approach.

Authors:  Irene Wen-Hui Tu; Nicholas Brian Shannon; Krishnakumar Thankappan; Deepak Balasubramanian; Vijay Pillai; Vivek Shetty; Vidyabhushan Rangappa; Naveen Hedne Chandrasekhar; Vikram Kekatpure; Moni Abraham Kuriakose; Arvind Krishnamurthy; Arun Mitra; Arun Pattatheyil; Prateek Jain; Subramania Iyer; Narayana Subramaniam; N Gopalakrishna Iyer
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

5.  Comparison of Different Staging Systems Applied to a Cohort of Patients With Oral Tongue and Floor of the Mouth Cancer.

Authors:  Lorenzo Bresciani; Lorenzo Giannini; Alberto Paderno; Fabiola Incandela; Walter Fontanella; Davide Mattavelli; Cesare Piazza
Journal:  Front Oral Health       Date:  2021-09-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.